New pill could help restore skin color in vitiligo patients
NCT ID NCT07172347
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 32 times
Summary
This study tests a new tablet called VC005 for people with non-segmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the drug can reduce the size of these patches on the face over 24 weeks. About 120 adults aged 18 to 70 will take part, and neither they nor their doctors will know who gets the real drug versus a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SEGMENTAL VITILIGO are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Peking University People's Hospital
RECRUITINGBeijing, Beijng, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.